David Mcelroy Email & Phone Number

Business and product development strategy planning, company formation and consulting for agricultural and industrial biotechnology. Clients include Calysta BioSystems, DNA2.0 Inc., Intrexon Corp, Mendel Biotechnology Inc., Advanta India Inc., Arzeda Corp, BioArchitecture Labs, Khosla Ventures

Penicuik, Edinburgh, Gb

Green Bioactives is developing a plant cell-based natural product manufacturing platform for diverse applications. Plant-derived natural products are used in diverse products across cosmetics, pharma, food and agriculture. These products are often sourced from host plants that are rare, protected, endangers and/or growing in remote locatations subject to local seasonality, weather, poor soil conditions and/or disease that adversly impact their supply chain. Plant cell culture represents a more sutainable biomanufacturing alternative to wild harvest. Our mission is to develop a technology-driven platform to biomanufacture plant natural products at elevated yields that others cannot achieve - enabling new product opportunities across a diverse range of industries/applications.

Midlothian, Gb

Ingenza is a synthetic biology/biotechnology R&D company with a customer base across bio-based chemicals, biopharma, consumer goods, food/feed and biofuel industries. Key responsibilities:• Company Strategyo Execute long term business strategy and produce communication materials/financials for stakeholders.• Business Development/Marketingo Expand relationships to access new business sectors with new and existing customers.o Identify 3rd party providers to either a) in-license from and/or b) establish strategic collaborations with in order to access complimentary assets.• Corporate Development/Fundingo Pursue potential sources of investment money and “pitch” to potential funding sources.• IP/Competitive Intelligence/Licensing/Legalo Responsible for drafting and negotiating all company legal contracts.o Editing patent applications and analysis for FTO.• Research Operations/Program Managemento Overseeing research activities to meet project milestones including defining key go/no go validation stages.o Maintain financial projections around the commercialization of products.• Regulatory Strategy/Complianceo Maintain compliance with regulatory requirements and develop long term strategic plans for regulatory approvals.Key Results:o Successfully transitioned Ingenza from biotechnology R&D services to an early stage biologics product development company.o Secured of multi-million £ government funding to support transition biologics production-based business.o Multiple patent applications submitted and trade mark protection successfully secured for branding assets.o Multiple new customer relationships secured and existing customer relationships expandedo CE marking secured for commercialisation of key company diagnostic device.o Development and commercialisation of biofuel yeast product.o Successful funding in the areas of green hydrogen / decarbonisation, agritech and biopharma development and production.

Work with the Management Team to define and refine the company strategy/business plans and execute on associated business development activities including negotiation and creation of partnership, sales, and licensing agreements.Contribute to business strategy execution, including goals development/review and financial review/planning.Lead Nova Synthetix through the evaluation of investment, collaboration and exit opportunities, including M&A activities.

San Mateo, California, Us

Founded Calysta LLC (Menlo Park, CA), a synthetic biology company looking to exploit gene library design/screening, computational biology and metabolic engineering through to industrial process development with a focus on products targeting natural gas-to-liquid fuels and chemicals.• Company formation and operating, services and license document drafting/negotiation; product selection, business plan development and IP strategy development/execution; budget development and staffing and company business development.• Key Result:o Secured $5.00mm seed investment from parent company to fund spin-out to support.o Completion of three initial technology in-licensing deals.

Targeted Growth, Inc. (Seattle, WA) is a crop biotechnology company focused on developing products with enhanced yield and improved quality for the agriculture and energy industries with activities in oilseeds for biojet fuel application, microalgae for biobased material production and yield traits for improved crop productivity.• Implementation and management of annual strategic planning process.• Responsible for the implementation of a strategy-driven goal setting and monitoring process linked to the annual budget scenario development process with associated resource and capacity planning processes across TGI R&D areas including agricultural crops, biofuel crops and algal biobased materials programs.• Responsible for all technology in-licensing (e.g. herbicide tolerance trait in-license for small grain cereal applications) and the establishment of research collaboration (e.g. yield trait evaluation agreement in oilseed crops with top tier agribusiness 02/07).• Established companywide IP management committee including docket review process and management of outside counsel activities.• Developed and implemented new strategy/annual objective-driven budget development/modeling and ongoing management processes companywide. Responsible for management of all administrative and finance functions across the company.• Developed and implemented new policies (e.g. credit card, travel, PTO, relocation, expense reporting and reimbursement, vehicle) and SOPs (e.g. hiring, purchasing, capital project justification and procurement, capital project tracking) companywide.• Key Results:o Negotiated, drafted and closed several dozen field trial and university contracts/agreements.o Extended partner collaboration worth >$70mm in total milestones.o Spun out new business entities in the areas of algal (Matrix Genetics) and crop based biofuels (Sustainable Oils) and hired senior executives to lead the programs.

Wilmington, De, Us

• Developed long (10yr) and intermediate (5 yr) term strategic innovation framework for R&D to communicate and supports business-driven product strategy allowing staff to see how individual actions contribute to achieving overall strategy.• Developed a prioritized list of the near and long term product and process initiatives linked to specific business strategies balanced with the ability to execute successfully.• Generated functional budget targets for operating and capital plans that links resource allocation and future resource capacity plans to strategic priorities.• Provided technical expertise in order to plan, track and execute strategy for new agbiotech trait product introduction, including resource constraint identification and resolution. Implementing operating plans and clarifying FTO/IP strategies to introduce new trait products into the market. Management of product champions across Pioneer R&D.• Management of DeltaMax Cotton LLC joint venture. Development and execution of Pioneer/DuPont business development strategy on cotton.• Management of trait and technology license activities. Establish R&D partnerships, technical and commercial diligence in deal negotiation, partnership project selection. Supervise activities of Business Development Manager. • Key Results:o Negotiated amendment to JV agreement - financial terms undisclosed.o Transformed research project management and planning from an activity-based process to a goal and product-focused process.o Completed numerous technology in-licensing and multi-million dollar strategic collaborations between Pioneer and both large and small technology providers – financial terms undisclosed

• Manage budget & finance activities, including facilities and capital equipment, supervise activities of Operations Managers, and participate in goal setting and establishment of incentives and rewards for staff of 50 at Verdia, Inc.• Execution of an integrated technical and business strategy. Establish R&D partnerships, technical and commercial diligence in deal negotiation, partnership project selection. Supervise activities of Business Development Manager.• Participate in partnership research management committees for project management, product development, and product commercialization. Supervise activities of Verdia’s Partnership Program Managers.• Product portfolio management, IP evaluation, technology licensing, project development, and partnering. Supervise activities of Internal Program Managers.• Key Resultso Syngenta partnership established (1999) and extended (2003) with multi-million dollar investment. Five undisclosed products in development with partners (year end 2004).o MaxyAg spun out a separate business entity with multi-million dollar investment by Maxygen (2002)o DeltaMax Cotton JV established with investment by Delta & Pineland Co. (2002). Two undisclosed Verdia cotton products in development (year end 2004).o Management of >$15 million operating budget (2004) controlling year-on-year cash burn while expanding Verdia research capabilities, product development capacity and research partnerships - Increased annual revenue by 20% through 2004.o Negotiation of sale of Verdia to Dupont in 2004 for $64mm.

St. Louis, Missouri, Us

• Molecular biology discovery research lead for company corn biotechnology program.• Key Results:o Phospinorthicin herbicide tolerant corn (B16) commercialized in 1996o Insect tolerant corn (DBT418) commercialized in 1997o Glyphosate herbicide tolerant corn (GA21) commercialized in 1998 – estimated annual global revenue to Monsanto from GA21 product sales 2005-2010 - >$500mm/yr.PATENTS:Spencer T.M., Mumm R., Gwyn J.J., McElroy D., Stephens M.A. 2008 Method for plant breeding. US 7,314,970Spencer T.M., Mumm R., Gwyn J.J., Stephens M.A., McElroy D. 2007. Use of glyphosate resistant maize lines. EP 0975778 B8Spencer T.M., Mumm R., Gwyn J.J., McElroy D., Stephens M.A. 2004. Method of plant breeding. US 6,762,344.McElroy D., Orozco E.M., Laccetti L.B. 2004. Maize glycine rich protein promoter composition and method of use therefore. US 6,747,189.McElroy, D., Walters, D., Gilbertson, L.A. 2004. Homologous recombination-mediated transgene alterations in plants. US 6,750,379.McElroy, D., Walters, D., Gilbertson, L.A. 2003. Non-reciprocal recombination-mediated transgene deletion in transgenic plants. US 6,580,019.McElroy D., Kriz A.L., Orozco E.M., Griffor, M. 2001. Maize A3 promoter and methods for use thereof. US 6,583,338.McElroy D., Orozco E.M., Laccetti L.B. 2002. Maize RS81 promoter and methods of use therefore. US 6,437,217.McElroy D., Orozco E.M., Laccetti L.B. 2002. Maize RS342 promoter and methods of use therefore. US 6,426,446.McElroy D., Kriz A.L., Orozco E.M., Griffor, M. 2001. Maize A3 promoter and methods for use thereof. US 6,232,526.McElroy D., Orozco E.M., Laccetti L.B. 2001. Maize RS81 promoter and methods of use therefore. US 6,207,879.McElroy D., Orozco E.M., Laccetti L.B. 2001. Maize RS342 promoter and methods of use therefore. US 6,194,636.Spencer T.M., Mumm R., Gwyn J.J., McElroy D., Stephens M.A. 1998. Glyphosate resistant maize lines. WO 9844140, US 08927368, US 2005/86719.

Barley genetic engineering in the lab of Dr. Peggy Lemaux (http://pmb.berkeley.edu/profile/plemaux).PATENTS:Koprek Y., McElroy D., Lemaux P. 2005. Transposon tagging and gene delivery in small grain cereals. US 6,951,972.

Acton, Act, Au

Wheat and barley tissue culture and genetic engineering

Amp, Management

Ph.D., Plant Molecular Biology

Bachelor Of Science (Bsc - Hons, 1St Class), Plant Sciences